"The minute we got FDA approval, we started to get requests for orders," says Gavriely, adding that physicians, nurses, paramedics, technicians and other health care professionals will be the first to use the WheezoMeter™ on asthmatic patients.
Gavriely says the device should become available for home use next year, via prescription, and later purchased over the counter, "like a glucometer or blood pressure monitor."
Ad Statistics
Times Displayed: 125799
Times Visited: 7246 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
KarmelSonix believes the handheld tool is not only an "excellent quality control measure" but that it could also prove to be a significant money-saver.
"Not being able to make an accurate and viable diagnosis is very costly," says Gavriely, noting that the average cost of asthma prescription medications per patient costs around $1,600 a year.
According to an American Lung Association 2009 report, asthma ranks as one of the country's top 10 prevalent conditions that limit activity and it costs billions to treat. "Prescription drugs represent the largest single direct medical expenditure, at $6.2 billion," the report states.
"[This technology] is a milestone for us and, hopefully, a new paradigm in asthma management."
Back to HCB News
